rdcjournalRoyal Dental College JournalE-Volume 8 Issue 1MultidisciplinaryEnglishJanuary- DecemberNNY20251030Oral Medicine and Radiology Herpes Zoster with Post Herpetic Neuralgia - A Case ReportEnglishY13AjmalMohamed1EnglishNYamunaRani2EnglishYGaneshSL2EnglishYRosieJoseph3EnglishYHerpes zoster is a transient disease characterized by a dermatomal rash that is usually associated with significant pain. Post-herpetic neuralgia (PHN) is the term used for the condition that exists if the pain persists after the rash has resolved. Advanced age and compromised cell-mediated immunity are significant risk factors for reactivation of herpes zoster and the subsequent development of PHN. This is a case report of herpes zoster with post herpetic neuralgia in a 60-year-old male patient with multiple blisters on the right side of the face which was treated with valacyclovir 1000mg and carbamazepine 300 mg.EnglishHerpes zoster, Neuralgia, Post herpetic neuralgiahttps://rdcjournal.org/abstract?id=276References1619REFERENCES 1.and;nbsp;Francis M, Subramanian K, Sankari SL, Potluri VL, Prabakaran A. Herpes zoster with post herpetic neuralgia involving the right maxillary branch of trigeminal nerve: a case report and review of literature. J Clin Diagn Res. 2017 Jan1;11(1):ZD40-ZD42.doi: 10.7860/JCDR/2017/22590.9237. 2.and;nbsp;Christo PJ, Hobelmann G, Maine DN. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs and;amp; aging. 2007 Jan;24(1):1-19. doi: 10.2165/00002512-200724010-00001. 3.and;nbsp;.Jiang X, Li Y, Chen N, Zhou M, He L. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews. 2023 Dec 5;12(12):CD005582. doi: 10.1002/14651858.CD005582. 4.and;nbsp;Cao X, Zhang X, Meng W, Zheng H. Herpes zoster and postherpetic neuralgia in an elderly patient with critical COVID-19: a case report. Journal of Pain Research. 2020 Sep 22:2361-5. doi: 10.2147/JPR.S274199. 5.and;nbsp;Schutzer-Weissmann J, Farquhar-Smith P. Post-herpetic neuralgiaand;ndash;a review of current management and future directions. Expert Opinion on Pharmacotherapy. 2017 Nov 2;18(16):1739-1750. doi: 10.1080/14656566.2017.1392508. 6.and;nbsp;Kim JH, Apigo A, Fontaine C. Dorsal root ganglion stimulation for refractory post-herpetic neuralgia. Pain Practice. 2021 Sep;21(7):794-8. doi: 10.1111/papr.13017. 7.and;nbsp;Sood SK, Jain M, Likhithaswamy HR, Agarwal B. Post Herpetic Neuralgia- A Case Report, Educational Administration: Theory and Practice. 2024;30(5):6257-6262. doi:10.53555/kuey.v30i5.3927. 8.and;nbsp;Chawki S, Vilcu AM, Etienne C, Finet F, Blanchon T, Souty C, et al. Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: a register-based population study. Journal of Infection 2022;84(4):531-6. 9.and;nbsp;Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged and;ge; 50 years in China: data from an integrated health care network. Journal of Infection 2021;82(2):253-60. 10.Shaparin N, Slattum PW, Bucior I, Nalamachu S. Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin. Clin J Pain. 2015 Nov;31(11):983-91. doi: 10.1097/AJP.0000000000000206.